We are excited to share the news that MyCural has successfully closed a new funding round, marking an important milestone for the company and its mission.

With the support of both returning and new investors, MyCural has been able to accelerate its chemistry program at an impressive pace. This momentum brings the team significantly closer to developing new therapeutic options for patients with high unmet medical needs, a goal that sits at the center of their scientific ambition.

MyCural expressed deep gratitude for the confidence placed in their work, their team, and their research. The commitment shown by investors not only strengthens the company’s progress today but also fuels the next phase of discovery and development.

We look forward to following MyCural’s continued journey and the impact its innovation will bring to the field.

Stay tuned for more updates as the company advances toward its next milestones.